{
    "clinical_study": {
        "@rank": "139669", 
        "arm_group": [
            {
                "arm_group_label": "Clostridium difficile carriers"
            }, 
            {
                "arm_group_label": "Clostridium difficile non carriers"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators hypothesize that development of symptoms characteristic of Clostridium\n      difficile infection will be 2-3 times higher in asymptomatic carriers, compared to that  of\n      non carriers and expect to find risk factors for development of symptomatic clostridium\n      difficile."
        }, 
        "brief_title": "The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers", 
        "condition": [
            "Clostridium Difficile", 
            "Colitis"
        ], 
        "condition_browse": {
            "mesh_term": "Colitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  History of hospitalization in recent year, residence of a nursing home or\n             institutions\n\n          -  Expected more than 48 hours hospitalization\n\n        Exclusion Criteria:\n\n          -  Colitis/ diarrhea\n\n          -  Rectal swab performed \u226548 hrs post arrival to hospital."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Newly admitted patients in the Emergency Department and Internal wards, ."
            }
        }, 
        "enrollment": {
            "#text": "744", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02063282", 
            "org_study_id": "ShaareZMC"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Asymptomatic", 
            "Carriage", 
            "Colonization", 
            "Clostridium difficile", 
            "Colitis", 
            "Rectal swab"
        ], 
        "lastchanged_date": "February 13, 2014", 
        "link": [
            {
                "url": "http://archinte.jamanetwork.com/article.aspx?articleid=622162"
            }, 
            {
                "url": "http://archinte.jamanetwork.com/article.aspx?articleid=1697791"
            }, 
            {
                "url": "http://www.ajicjournal.org/article/S0196-6553(12)01303-X/abstract"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Jerusalem", 
                    "country": "Israel"
                }, 
                "name": "Shaare Zedek Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Yonit Wiener-Well, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Eliyahu Ben Shitrit, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Shelly Kagan", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Amos M Yinnon, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "2", 
        "official_title": "The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers", 
        "overall_contact": {
            "email": "yinnon@szmc.org.il", 
            "last_name": "Amos Yinnon, Professor", 
            "phone": "02-6555147"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Israeli Health Ministry Pharmaceutical Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "participants will be followed for the duration of hospital stay, an expected average of 4 weeks.\nPatients' file will be reviewed and the next signs and symptoms will be recorded: abdominal pain, diarrhea, fever and leukocytosis.", 
            "measure": "Development of colitis", 
            "safety_issue": "No", 
            "time_frame": "Daily follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02063282"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shaare Zedek Medical Center", 
            "investigator_full_name": "Amos Yinnon", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "participants will be followed for the duration of hospital stay, an expected average of 4 weeks.\nPatients' file will be reviewed and the next signs and symptoms will be recorded: abdominal pain, diarrhea, fever and leukocytosis.", 
                "measure": "Duration until development of colitis", 
                "safety_issue": "No", 
                "time_frame": "Daily follow-up"
            }, 
            {
                "description": "participants will be followed for the duration of hospital stay, an expected average of 4 weeks.\nPatients' file will be reviewed and the next signs and symptoms will be recorded: abdominal pain, diarrhea, fever and leukocytosis.", 
                "measure": "Severity of colitis", 
                "safety_issue": "No", 
                "time_frame": "Daily follow-up"
            }
        ], 
        "source": "Shaare Zedek Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Amos Yinnon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "2 Weeks", 
        "verification_date": "February 2014"
    }
}